HomeLoginJoinSitemapContact English
 

Ȩ > ¾Ë¸²¸¶´ç > ¿¡³ÊÁö°­ÁÂ

¿¬»ç Prof. Luke P. Lee
°­ÁÂÀϽà 2014³â 4¿ù 1ÀÏ  ¿ÀÈÄ 17:00 ~ 18:00
°­Á Á¦¸ñ Bionanoscience for Innovative Global Healthcare Research & Technology (BIGHEART)
÷ºÎÆÄÀÏ ¸ÖƼ½ºÄÉÀÏ¿¡³ÊÁö°­ÁÂ_UC Berkeley_Luke P. Lee_20140401.pptx (147.85KB)  

¹Ì·¡Ã¢Á¶°úÇкΠ±Û·Î¹úÇÁ·ÐƼ¾î (Àç)¸ÖƼ½ºÄÉÀÏ ¿¡³ÊÁö ½Ã½ºÅÛ ¿¬±¸´ÜÀº ³ª³ë±â¼ú°ú ¿¡³ÊÁö
±â¼úÀÇ À¶ÇÕÀ» ÅëÇÏ¿© Çõ½ÅÀû ¹Ì·¡ ±¤¿¡³ÊÁö¿Í ºÐÀÚ¿¡³ÊÁö ¿øõ±â¼ú °³¹ßÀ» ¸ñÇ¥·Î ÇÏ´Â ¸ÖƼ½ºÄÉÀÏ ¿¡³ÊÁö ½Ã½ºÅÛ ¿¬±¸»ç¾÷À» ÃßÁøÇÏ°í ÀÖ½À´Ï´Ù. ¿¬±¸´Ü¿¡¼­´Â °ÝÁÖ·Î ¸ÖƼ½ºÄÉÀÏ ¿¡³ÊÁö   °­Á¸¦ °³ÃÖÇÕ´Ï´Ù. °ü½É ÀÖ´Â ºÐµéÀÇ ¸¹Àº Âü¼® ¹Ù¶ø´Ï´Ù.

1. Á¦  ¸ñ : Bionanoscience for Innovative Global Healthcare Research & Technology  (BIGHEART)
2. ¿¬  »ç : Prof. Luke P. Lee (Institute of Quantitative Biosciences, UC Berkeley)
3. ÀÏ  ½Ã : 2014³â 4¿ù 1ÀÏ (È­) ¿ÀÈÄ 17:00 ~ 18:00
4. Àå  ¼Ò : ¼­¿ï´ëÇб³ ½Å°øÇаü(301µ¿) 102È£ °­ÀǽÇ

5. ³»  ¿ë :
Abstract :
Modern medicine has the potential of becoming both more personalized-and low cost-thanks to recent discoveries at the intersection of molecular biology, chemistry, and engineering physics. I will speak about using optical controls of our individual gene circuits in living cells for the treatment of cancer, infectious diseases and neurological diseases. I will also describe an integrated molecular diagnostic system, which, with the help of cell phones and GPS, will enable epidemiological surveying and remote healthcare delivery. These are just two examples of new solutions made possible by bionanoscience to some of the greatest challenges in global healthcare. I will share my vision of BIGHEART, which requires the convergence of integrative art, culture, and technology and science (iACTS).  The BIGHEART with iACTS can solve ill-defined real-world problems of global healthcare in both developed and developing world.

6. ¾à  ·Â :
Luke P. Lee is the Arnold and Barbara Silverman Distinguished Professor of Bioengineering, Electrical Engineering & Computer Science, Biophysics at UC Berkeley.  He also serves as Co-Director of Berkeley Sensor & Actuator Center.  He received both his BA and PhD from UC Berkeley.  He joined the faculty at the UC Berkeley in 1999, and then became the Lester John and Lynne Dewar Lloyd Distinguished Professor of Bioengineering and Professor of Biophysics at Berkeley in 2005. He also served as the Chair Professor in Systems Nanobiology at the Swiss Federal Institute of Technology (ETH, Zürich) from 2006 to 2007. His work at the interface of biological, physical, and engineering sciences for medicine has been recognized by many honors that include the William J. Morlock Award, NSF Career Award, and the HoAm Prize.  He is a Fellow of the Royal Society of Chemistry and the American Institute of Medical and Biological Engineering. His current research interests are quantum nanobiology, integrative molecular diagnostics of infectious and neurodegenerative diseases, mechanisms of morphogenesis: the creation of biological form, bioinspired neural interfaces, and solving both developed and developing world healthcare challenges.  http://biopoets.berkeley.edu

¹®  ÀÇ : ¸ÖƼ½ºÄÉÀÏ ¿¡³ÊÁö ½Ã½ºÅÛ ¿¬±¸´Ü ¿¬±¸Áö¿øº»ºÎ (¢Î 889-6669,6670)
           ³²±âÅ ±³¼ö (Àç·á°øÇкÎ), ÃÖ¸¸¼ö ±³¼ö (±â°èÇ×°ø°øÇкÎ)


¸ñ·ÏÀ¸·Î